tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market
BCLI
Brainstorm Cell Therapeutics
RESEARCH TOOLSreports

Brainstorm Cell Therapeutics (BCLI) Financial Statements

572 Followers

Brainstorm Cell Therapeutics Financial Overview

Brainstorm Cell Therapeutics's market cap is currently $9.52M. The company's EPS TTM is $-0.221; its P/E ratio is ―; Brainstorm Cell Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 703.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -240.00K$ -265.00K$ -285.00K$ -260.00K
Operating Income$ 0.00$ -11.69M$ -21.44M$ -24.82M$ -24.54M
EBITDA$ 0.00$ -11.31M$ -16.93M$ -23.99M$ -24.28M
Net Income$ 10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Balance Sheet
Cash & Short-Term Investments$ 29.00K$ 187.00K$ 1.30M$ 2.98M$ 22.09M
Total Assets$ 715.00K$ 1.83M$ 4.21M$ 8.45M$ 29.28M
Total Debt$ 208.00K$ 720.00K$ 1.27M$ 4.09M$ 5.08M
Net Debt$ 179.00K$ 533.00K$ -25.00K$ 3.32M$ -13.78M
Total Liabilities$ 11.01M$ 9.60M$ 9.07M$ 11.47M$ 9.94M
Stockholders' Equity$ -10.29M$ -7.76M$ -4.86M$ -3.02M$ 19.34M
Cash Flow
Free Cash Flow$ -6.97M$ -9.09M$ -20.48M$ -19.35M$ -26.59M
Operating Cash Flow$ -6.97M$ -9.09M$ -20.46M$ -19.32M$ -26.27M
Investing Cash Flow$ 0.00$ 12.00K$ 2.19M$ 998.00K$ 323.00K
Financing Cash Flow$ 0.00$ 7.97M$ 18.98M$ 238.00K$ 6.97M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Income Statement >

Brainstorm Cell Therapeutics Debt to Assets

Balance Sheet >

Brainstorm Cell Therapeutics Cash Flow

Cash Flow >

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS

Earnings >